Dose escalation of a curcuminoid formulation
University of Michigan · Michigan Medicine · +3 more institutions
Indexed incrossrefdoajpubmed
Abstract
Background
Curcumin is the major yellow pigment extracted from turmeric, a commonly-used spice in India and Southeast Asia that has broad anticarcinogenic and cancer chemopreventive potential. However, few systematic studies of curcumin's pharmacology and toxicology in humans have been performed.
Methods
A dose escalation study was conducted to determine the maximum tolerated dose and safety of a single dose of standardized powder extract, uniformly milled curcumin (C3 Complextrade mark, Sabinsa Corporation). Healthy volunteers were administered escalating doses from 500 to 12,000 mg.
Citation impact
1,372
total citations
- FWCI
- 9.58
- Percentile
- 100%
- References
- 22
Citations per year
Authors
10Topics & keywords
Topics
Keywords
- Curcumin
- Curcuminoid
- Medicine
- Bioavailability
- Pharmacology
- Traditional medicine
- Toxicity
- Internal medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.